[Startups to Watch] 'Vuno puts doctors’ needs ahead of marketability in developing products’
The rise of artificial intelligence (AI) has thrown pharmaceutical companies and medical device into a race to develop new products and services to open the age of AI healthcare.Korea also has been approving, slowly but steadily, new AI medical devices for use in the clinical field while setting up
Regulator cautions investors against betting on biotech shares
The Financial Services Commission (FSC) issued a warning on retail investors, saying they should be aware of investment risks in local biotech and pharmaceutical stocks.The FSC announced the “Notes on investing into biotech and pharmaceutical shares” on Thursday.“Biotech and pharmaceutical shares ha
[Special] When will Koreans start using digital therapeutics?
Digital therapeutics can fill gap in public healthcare: LifeSemantics CEO
Digital therapeutics can be classified as medicine and non-medicine at the same time. People regard a drug as a product made from synthetic or natural ingredients, taken orally, or injected. A dictionary defines medicine as “a substance used in treating or preventing diseases or wounds, taken orally
65% of gastroenterologists show burnout symptoms
Korean gastroenterologists were suffering from a high level of burnout, a study showed. Burnout refers to physical and psychological exhaustion due to prolonged work and stress, causing lethargy in the end.Doctors have various tasks, such as medical treatment, surgery, and research. Excessive work c
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
Eisai's Lenvima, a hepatocellular carcinoma treatment, has managed to show improved response rate and overall survival when compared to Bayer's Nexavar, Eisai Korea said Wednesday. Professor Yoo Chang-hoon at Asan Medical Center explains the superior efficacy of Lenvima, during a